Pepijn Vemer

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Author's Reply.

Author's Reply.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: December 17, 2019

The risk of overestimating cost savings from hospital-at-home schemes: A literature review.

The risk of overestimating cost savings from hospital-at-home schemes: A literature review.

Journal: International journal of nursing studies

Published: July 18, 2019

Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier.

Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 02, 2018

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review.

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review.

Journal: PloS one

Published: October 15, 2018

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research.

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research.

Journal: PharmacoEconomics

Published: September 22, 2017

A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data.

A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: December 03, 2016

Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands.

Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands.

Journal: Leukemia research

Published: May 20, 2016

Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.

Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.

Journal: PharmacoEconomics

Published: May 01, 2016

An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands.

An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: April 26, 2016

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data.

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data.

Journal: PloS one

Published: March 09, 2016

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.

Journal: PharmacoEconomics

Published: December 15, 2015

Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital.

Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital.

Journal: PloS one

Published: December 09, 2015

Showing 1-12 of 27

Last Updated: 09/26/2026